The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Annals of the Rheumatic Diseases 70.4 (2011): S. 695-699.
- Schlagwort
-
-
Hautkrankheit
Dermatologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2011
- Urheber
-
Balistreri, Epifania
Garcia-Gonzalez, Estrella
Selvi, Enrico
Akhmetshina, Alfiya
Palumbo, Katrin
Lorenzini, Sauro
Maggio, Roberta
Lucattelli, Monica
Galeazzi, Mauro
Distler, Jörg W. H.
- URN
-
urn:nbn:de:bvb:29-opus4-77863
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:50 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Balistreri, Epifania
- Garcia-Gonzalez, Estrella
- Selvi, Enrico
- Akhmetshina, Alfiya
- Palumbo, Katrin
- Lorenzini, Sauro
- Maggio, Roberta
- Lucattelli, Monica
- Galeazzi, Mauro
- Distler, Jörg W. H.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2011
Ähnliche Objekte (12)
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis
Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis
Stimulation of soluble guanylate cyclase reduces experimental dermal fibrosis
Activation of pregnane X receptor inhibits experimental dermal fibrosis
The LIM-only protein FHL2 attenuates lung inflammation during bleomycin-induces fibrosis
Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Lung surfactant as pirfenidone vehicle for the treatment of bleomycin induced pulmonary fibrosis
Bleomycin (Mack)
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin]
Ausscheidung und Organverteilung von 57Co-Bleomycin [Co-Bleomycin] und Therapieexperimente mit Bleomycin im Meerschweintumormodell